What is HC Wainwright’s Forecast for TRVI Q2 Earnings?
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Analysts at HC Wainwright issued their Q2 2025 earnings estimates for Trevi Therapeutics in a research note issued on Wednesday, May 28th. HC Wainwright analyst B. Folkes forecasts that the company will post earnings of ($0.13) per share for the quarter. HC Wainwright has a “Buy” rating […]
